Mast cell mediator responses and their suppression by pathogenic and commensal microorganisms

Molecular Immunology

Volumn 63, Issue 1, 2015, Pages 74-79

  Choi, Hae Woong ^a   Abraham, Soman N ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Anti inflammatory; Commensal; Degranulation; Infection; Mast cell suppression; Mast cells; Pathogen

Indexed keywords

COMMENSAL; HOST; HUMAN; INFECTION; INNATE IMMUNITY; MAST CELL; MAST CELL DEGRANULATION; MEDIATOR RELEASE; NONHUMAN; PATHOGEN LOAD; REVIEW; SALMONELLA; BACTERIAL INFECTION; BIOSYNTHESIS; CELL GRANULE; IMMUNE EVASION; IMMUNOLOGY; MYCOSIS;

ANTIMICROBIAL CATIONIC PEPTIDE; CYTOKINE; HISTAMINE; ICOSANOID;

ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIAL INFECTIONS; CYTOKINES; CYTOPLASMIC GRANULES; EICOSANOIDS; HISTAMINE; HUMANS; IMMUNE EVASION; IMMUNITY, INNATE; MAST CELLS; MYCOSES;

EID: 84908549440     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2014.02.006     Document Type: Review

References (70)

1. Armstrong G.L., Conn L.A., Pinner R.W. Trends in infectious disease mortality in the United States during the 20th century. JAMA 1999, 281:61-66.
2. Abraham S.N., St.John A.L. Mast cell-orchestrated immunity to pathogens. Nat. Rev. Immunol. 2010, 10:440-452.
3. Marshall J.S. Mast-cell responses to pathogens. Nat. Rev. Immunol. 2004, 4:787-799.
4. Cheng L.E., Hartmann K., Roers A., Krummel M.F., Locksley R.M. Perivascular mast cells dynamically probe cutaneous blood vessels to capture immunoglobulin E. Immunity 2013, 38:166-175.
5. Kunder C.A., St.John A.L., Li G., Leong K.W., Berwin B., Staats H.F., Abraham S.N. Mast cell-derived particles deliver peripheral signals to remote lymph nodes. J. Exp. Med. 2009, 206:2455-2467.
6. De Filippo K., Dudeck A., Hasenberg M., Nye E., van Rooijen N., Hartmann K., Gunzer M., Roers A., Hogg N. Mast cell and macrophage chemokines CXCL1/CXCL2 control the early stage of neutrophil recruitment during tissue inflammation. Blood 2013, 121:4930-4937.
7. Galli S.J., Tsai M. IgE and mast cells in allergic disease. Nat. Med. 2012, 18:693-704.
8. Malaviya R., Gao Z., Thankavel K., van der Merwe P.A., Abraham S.N. The mast cell tumor necrosis factor alpha response to FimH-expressing Escherichia coli is mediated by the glycosylphosphatidylinositol-anchored molecule CD48. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:8110-8115.
9. Munoz S., Hernandez-Pando R., Abraham S.N., Enciso J.A. Mast cell activation by Mycobacterium tuberculosis: mediator release and role of CD48. J. Immunol. 2003, 170:5590-5596.
10. Moon T.C., St.Laurent C.D., Morris K.E., Marcet C., Yoshimura T., Sekar Y., Befus A.D. Advances in mast cell biology: new understanding of heterogeneity and function. Mucosal. Immunol. 2010, 3:111-128.
11. Leal-Berumen I., Snider D.P., Barajas-Lopez C., Marshall J.S. Cholera toxin increases IL-6 synthesis and decreases TNF-alpha production by rat peritoneal mast cells. J. Immunol. 1996, 156:316-321.
12. Enoksson M., Moller-Westerberg C., Wicher G., Fallon P.G., Forsberg-Nilsson K., Lunderius-Andersson C., Nilsson G. Intraperitoneal influx of neutrophils in response to IL-33 is mast cell-dependent. Blood 2013, 121:530-536.
13. Liew F.Y., Pitman N.I., McInnes I.B. Disease-associated functions of IL-33: the new kid in the IL-1 family. Nat. Rev. Immunol. 2010, 10:103-110.
14. Moussion C., Ortega N., Girard J.P. The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel 'alarmin'?. PLoS One 2008, 3:e3331.
15. Gilfillan A.M., Tkaczyk C. Integrated signalling pathways for mast-cell activation. Nat. Rev. Immunol. 2006, 6:218-230.
16. Kovarova M., Tolar P., Arudchandran R., Draberova L., Rivera J., Draber P. Structure-function analysis of Lyn kinase association with lipid rafts and initiation of early signaling events after Fcepsilon receptor I aggregation. Mol. Cell. Biol. 2001, 21:8318-8328.
17. Chen T., Repetto B., Chizzonite R., Pullar C., Burghardt C., Dharm E., Zhao Z., Carroll R., Nunes P., Basu M., et al. Interaction of phosphorylated Fc epsilon RI gamma immunoglobulin receptor tyrosine activation motif-based peptides with dual and single SH2 domains of p72syk. Assessment of binding parameters and real time binding kinetics. J. Biol. Chem. 1996, 271:25308-25315.
18. Saitoh S., Arudchandran R., Manetz T.S., Zhang W., Sommers C.L., Love P.E., Rivera J., Samelson L.E. LAT is essential for Fc(epsilon)RI-mediated mast cell activation. Immunity 2000, 12:525-535.
19. Beaven M.A., Metzger H. Signal transduction by Fc receptors: the Fc epsilon RI case. Immunol. Today 1993, 14:222-226.
20. Ozawa K., Szallasi Z., Kazanietz M.G., Blumberg P.M., Mischak H., Mushinski J.F., Beaven M.A. Ca(2+)-dependent and Ca(2+)-independent isozymes of protein kinase C mediate exocytosis in antigen-stimulated rat basophilic RBL-2H3 cells. Reconstitution of secretory responses with Ca2+ and purified isozymes in washed permeabilized cells. J. Biol. Chem. 1993, 268:1749-1756.
21. Sudhof T.C., Rothman J.E. Membrane fusion: grappling with SNARE and SM proteins. Science 2009, 323:474-477.
22. Rizo J., Rosenmund C. Synaptic vesicle fusion. Nat. Struct. Mol. Biol. 2008, 15:665-674.
23. Mustelin T., Vang T., Bottini N. Protein tyrosine phosphatases and the immune response. Nat. Rev. Immunol. 2005, 5:43-57.
24. Benhamou M., Blank U. Stimulus-secretion coupling by high-affinity IgE receptor: new developments. FEBS Lett. 2010, 584:4941-4948.
25. Malaviya R., Ikeda T., Ross E., Abraham S.N. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-alpha. Nature 1996, 381:77-80.
26. Echtenacher B., Mannel D.N., Hultner L. Critical protective role of mast cells in a model of acute septic peritonitis. Nature 1996, 381:75-77.
27. Meyers D.J., Berk R.S. Characterization of phospholipase C from Pseudomonas aeruginosa as a potent inflammatory agent. Infect. Immun. 1990, 58:659-666.
28. Abraham S., Shin J., Malaviya R. Type 1 fimbriated Escherichia coli-mast cell interactions in cystitis. J. Infect. Dis. 2001, 183(Suppl. 1):S51-S55.
29. Wei O.L., Hilliard A., Kalman D., Sherman M. Mast cells limit systemic bacterial dissemination but not colitis in response to Citrobacter rodentium. Infect. Immun. 2005, 73:1978-1985.
30. Velin D., Bachmann D., Bouzourene H., Michetti P. Mast cells are critical mediators of vaccine-induced Helicobacter clearance in the mouse model. Gastroenterology 2005, 129:142-155.
31. Ebmeyer J., Furukawa M., Pak K., Ebmeyer U., Sudhoff H., Broide D., Ryan A.F., Wasserman S. Role of mast cells in otitis media. J. Allergy Clin. Immunol. 2005, 116:1129-1135.
32. Xu X., Zhang D., Lyubynska N., Wolters P.J., Killeen N.P., Baluk P., McDonald D.M., Hawgood S., Caughey G.H. Mast cells protect mice from Mycoplasma pneumonia. Am. J. Respir. Crit. Care Med. 2006, 173:219-225.
33. Carruthers V.B., Giddings O.K., Sibley L.D. Secretion of micronemal proteins is associated with toxoplasma invasion of host cells. Cell. Microbiol. 1999, 1:225-235.
34. St.John A.L., Rathore A.P., Yap H., Ng M.L., Metcalfe D.D., Vasudevan S.G., Abraham S.N. Immune surveillance by mast cells during dengue infection promotes natural killer (NK) and NKT-cell recruitment and viral clearance. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:9190-9195.
35. King C.A., Marshall J.S., Alshurafa H., Anderson R. Release of vasoactive cytokines by antibody-enhanced dengue virus infection of a human mast cell/basophil line. J. Virol. 2000, 74:7146-7150.
36. King C.A., Anderson R., Marshall J.S. Dengue virus selectively induces human mast cell chemokine production. J. Virol. 2002, 76:8408-8419.
37. Brown M.G., King C.A., Sherren C., Marshall J.S., Anderson R. A dominant role for FcgammaRII in antibody-enhanced dengue virus infection of human mast cells and associated CCL5 release. J. Leukoc. Biol. 2006, 80:1242-1250.
38. Genovese A., Borgia G., Bouvet J.P., Detoraki A., de Paulis A., Piazza M., Marone G. Protein Fv produced during viral hepatitis is an endogenous immunoglobulin superantigen activating human heart mast cells. Int. Arch. Allergy Immunol. 2003, 132:336-345.
39. Marone G., de Paulis A., Florio G., Petraroli A., Rossi F.W., Triggiani M. Are mast cells MASTers in HIV-1 infection?. Int. Arch. Allergy Immunol. 2001, 125:89-95.
40. Orinska Z., Bulanova E., Budagian V., Metz M., Maurer M., Bulfone-Paus S. TLR3-induced activation of mast cells modulates CD8+ T-cell recruitment. Blood 2005, 106:978-987.
41. Sundstrom J.B., Ellis J.E., Hair G.A., Kirshenbaum A.S., Metcalfe D.D., Yi H., Cardona A.C., Lindsay M.K., Ansari A.A. Human tissue mast cells are an inducible reservoir of persistent HIV infection. Blood 2007, 109:5293-5300.
42. Bannert N., Farzan M., Friend D.S., Ochi H., Price K.S., Sodroski J., Boyce J.A. Human mast cell progenitors can be infected by macrophagetropic human immunodeficiency virus type 1 and retain virus with maturation in vitro. J. Virol. 2001, 75:10808-10814.
43. Marone G., Florio G., Petraroli A., de Paulis A. Dysregulation of the IgE/Fc epsilon RI network in HIV-1 infection. J. Allergy Clin. Immunol. 2001, 107:22-30.
44. Smith K.A. The frontiers publishing paradigm. Front. Immunol. 2012, 3:1.
45. Warris A., Netea M.G., Verweij P.E., Gaustad P., Kullberg B.J., Weemaes C.M., Abrahamsen T.G. Cytokine responses and regulation of interferon-gamma release by human mononuclear cells to Aspergillus fumigatus and other filamentous fungi. Med. Mycol. 2005, 43:613-621.
46. Huffnagle G.B., Strieter R.M., McNeil L.K., McDonald R.A., Burdick M.D., Kunkel S.L., Toews G.B. Macrophage inflammatory protein-1alpha (MIP-1alpha) is required for the efferent phase of pulmonary cell-mediated immunity to a Cryptococcus neoformans infection. J. Immunol. 1997, 159:318-327.
47. Crowle P.K., Reed N.D. Rejection of the intestinal parasite Nippostrongylus brasiliensis by mast cell-deficient W/Wv anemic mice. Infect. Immun. 1981, 33:54-58.
48. Mead P.S., Slutsker L., Dietz V., McCaig L.F., Bresee J.S., Shapiro C., Griffin P.M., Tauxe R.V. Food-related illness and death in the United States. Emerg. Infect. Dis. 1999, 5:607-625.
49. Majowicz S.E., Musto J., Scallan E., Angulo F.J., Kirk M., O'Brien S.J., Jones T.F., Fazil A., Hoekstra R.M. The global burden of nontyphoidal Salmonella gastroenteritis. Clin. Infect. Dis. 2010, 50:882-889. International Collaboration on Enteric Disease 'Burden of Illness S.
50. St.John A.L., Abraham S.N. Salmonella disrupts lymph node architecture by TLR4-mediated suppression of homeostatic chemokines. Nat. Med. 2009, 15:1259-1265.
51. Haraga A., Ohlson M.B., Miller S.I. Salmonellae interplay with host cells. Nat. Rev. Microbiol. 2008, 6:53-66.
52. Galan J.E. Salmonella interactions with host cells: type III secretion at work. Annu. Rev. Cell Dev. Biol. 2001, 17:53-86.
53. Kaniga K., Uralil J., Bliska J.B., Galan J.E. A secreted protein tyrosine phosphatase with modular effector domains in the bacterial pathogen Salmonella typhimurium. Mol. Microbiol. 1996, 21:633-641.
54. Choi H.W., Brooking-Dixon R., Neupane S., Lee C.-J., Miao E.A., Staats H.F., Abraham S.N. Salmonella typhimurium impedes innate immunity with a mast-cell-suppressing protein tyrosine phosphatase, SptP. Immunity 2013, 39:1108-1120.
55. Masuda E.S., Schmitz J. Syk inhibitors as treatment for allergic rhinitis. Pulm. Pharmacol. Ther. 2008, 21:461-467.
56. Cornelis G.R. Yersinia type III secretion: send in the effectors. J. Cell Biol. 2002, 158:401-408.
57. Magerl M., Lammel V., Siebenhaar F., Zuberbier T., Metz M., Maurer M. Non-pathogenic commensal Escherichia coli bacteria can inhibit degranulation of mast cells. Exp. Dermatol. 2008, 17:427-435.
58. Kawahara T. Inhibitory effect of heat-killed Lactobacillus strain on immunoglobulin E-mediated degranulation and late-phase immune reactions of mouse bone marrow-derived mast cells. Anim. Sci. J. 2010, 81:714-721.
59. Harata G., He F., Takahashi K., Hosono A., Kawase M., Kubota A., Hiramatsu M., Kaminogawa S. Bifidobacterium suppresses IgE-mediated degranulation of rat basophilic leukemia (RBL-2H3) cells. Microbiol. Immunol. 2010, 54:54-57.
60. Forsythe P., Wang B., Khambati I., Kunze W.A. Systemic effects of ingested Lactobacillus rhamnosus: inhibition of mast cell membrane potassium (IKCa) current and degranulation. PLoS One 2012, 7:e41234.
61. Oksaharju A., Kankainen M., Kekkonen R.A., Lindstedt K.A., Kovanen P.T., Korpela R., Miettinen M. Probiotic Lactobacillus rhamnosus downregulates FCER1 and HRH4 expression in human mast cells. World J. Gastroenterol. 2011, 17:750-759.
62. Wesolowski J., Paumet F. The impact of bacterial infection on mast cell degranulation. Immunol. Res. 2011, 51:215-226.
63. Cramer R.A., Gamcsik M.P., Brooking R.M., Najvar L.K., Kirkpatrick W.R., Patterson T.F., Balibar C.J., Graybill J.R., Perfect J.R., Abraham S.N., et al. Disruption of a nonribosomal peptide synthetase in Aspergillus fumigatus eliminates gliotoxin production. Eukaryot. Cell 2006, 5:972-980.
64. Niide O., Suzuki Y., Yoshimaru T., Inoue T., Takayama T., Ra C. Fungal metabolite gliotoxin blocks mast cell activation by a calcium- and superoxide-dependent mechanism: implications for immunosuppressive activities. Clin. Immunol. 2006, 118:108-116.
65. de Paulis A., Stellato C., Cirillo R., Ciccarelli A., Oriente A., Marone G. Anti-inflammatory effect of FK-506 on human skin mast cells. J. Invest. Dermatol. 1992, 99:723-728.
66. Hatfield S.M., Roehm N.W. Cyclosporine and FK506 inhibition of murine mast cell cytokine production. J. Pharmacol. Exp. Ther. 1992, 260:680-688.
67. Melendez A.J., Harnett M.M., Pushparaj P.N., Wong W.S., Tay H.K., McSharry C.P., Harnett W. Inhibition of Fc epsilon RI-mediated mast cell responses by ES-62, a product of parasitic filarial nematodes. Nat. Med. 2007, 13:1375-1381.
68. Smith N.L., Abi Abdallah D.S., Butcher B.A., Denkers E.Y., Baird B., Holowka D. Toxoplasma gondii inhibits mast cell degranulation by suppressing phospholipase Cgamma-mediated Ca(2+) mobilization. Front. Microbiol. 2013, 4:179.
69. Jenkins C.E., Swiatoniowski A., Issekutz A.C., Lin T.J. Pseudomonas aeruginosa exotoxin A induces human mast cell apoptosis by a caspase-8 and -3-dependent mechanism. J. Biol. Chem. 2004, 279:37201-37207.
70. Shortt C. The probiotic century: historical and current perspectives. Trends Food Sci. Technol. 1999, 10:411-417.